Use of methotrexate and risk of skin cancer: a nationwide case-control study

Medicine and Dentistry

• Case-Control Study 100%
• Skin Cancer 100%
• Methotrexate 100%
• Basal-Cell Carcinoma 83%
• Skin Carcinoma 83%
• Odds Ratio 66%
• Nodular Melanoma 50%
• Population Research 33%
• Psoriasis 33%
• Childbirth 16%
• Logistic Regression Analysis 16%
• Dose Response 16%

Keyphrases

• Methotrexate 100%
• Skin Cancer 100%
• Basal Cell Carcinoma 83%
• Cutaneous Squamous Cell Carcinoma (cSCC) 83%
• Metastatic Melanoma 50%
• Odds Ratio 33%
• Adjusted Odds Ratio 33%
• Psoriasis 33%
• Confidence Interval 16%
• Birth Timing 16%
• Dose-response 16%
• Conditional Logistic Regression 16%
• Response Pattern 16%
• Danish Case 16%
• Cumulative Dose 16%
• Crude Odds Ratio 16%
• Risk-set Sampling 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Case-Control Study 100%
• Methotrexate 100%
• Skin Cancer 100%
• Basal Cell Carcinoma 83%
• Skin Carcinoma 83%
• Melanoma 50%
• Population Study 33%
• Psoriasis 33%